Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700010168

Trial Profile

Clinical Trials Insight: 700010168

Phase of Trial: Phase II

Latest Information Update: 11 Mar 2008

At a glance

  • Drugs Cyclophosphamide; HRE gene therapy
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Mar 2008 Preliminary results have been reported by Oxford Biomedica.
    • 09 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top